RTOG 0848. A Phase III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma
Mitchel Fromm, MD
McDowell Cancer Research at 330-344-6348
Cleveland Clinic Akron General 1 Akron General Avenue Akron, OH 44307 330.344.6000 1.800.221.4601 © 2017 Cleveland Clinic Akron General
This site complies with the HONcode standard for trustworthy health information: verify here.